Naltrexone hydrochloride
Naltex and Naltrexone Accord are different trade names for the same medicine.
The active substance, naltrexone hydrochloride, belongs to a group of medicines that act on the nervous system - medicines used to treat addictions.
Naltrexone hydrochloride is used in combination with other medicines or other treatment methods to help patients addicted to opioids overcome their addiction.
Naltrexone blocks receptors in the brain, and in this way, blocks the action of opioids. Patients no longer experience a state of euphoria that they experienced after taking opioids.
Naltrexone hydrochloride is used as part of a comprehensive treatment program to help people addicted to alcohol maintain abstinence (self-restraint).
Naltex does not cause addiction.
If any of the above situations occur, you should not take the tablets. Before taking the medicine, you should inform your doctor and then follow their instructions.
Before starting treatment with Naltex, you should discuss it with your doctor or pharmacist:
If you have or have had any of the above circumstances, you should inform your doctor.
Naltrexone should not be given to children and adolescents under 18 years of age, due to insufficient clinical data in this age group. The safety of using naltrexone in children has not been established.
There is a lack of sufficient data on the safety and efficacy of naltrexone in the treatment of this indication in elderly patients.
You should tell your doctor or pharmacist about all medicines you are taking, have recently taken, or plan to take.
Some commonly used medicines contain opioids that may not work while taking Naltex. If you need cough medicines or anti-diarrheal medicines or painkillers, you should inform your doctor, as these medicines may contain opioids.
Despite the contraindications for concomitant use of opioid-containing medicines, in emergency situations, it may be necessary to administer a painkiller in a dose larger than usual. Absolute medical supervision is necessary, as the occurring respiratory depression and other symptoms may be stronger and longer-lasting.
Taking food and drink has no effect on Naltex therapy.
If you are pregnant or breastfeeding, think you may be pregnant or plan to have a child, you should consult your doctor or pharmacist before taking this medicine.
The safety of using Naltex during pregnancy has not been established.
It is not known whether naltrexone passes into breast milk. Due to the lack of established safety of using naltrexone in children and infants, you should not breastfeed while taking Naltex.
Naltrexone may affect your mental and/or physical ability to perform potentially hazardous activities such as driving or operating machinery.
If you have been told that you have an intolerance to some sugars, you should contact your doctor before taking the medicine.
This medicine should always be taken exactly as your doctor or pharmacist has told you.
If you are unsure, you should consult your doctor or pharmacist again.
The recommended dose is one tablet per day, unless your doctor prescribes otherwise.
If you have taken more tablets than recommended, you should immediately inform your doctor.
You can take Naltex as soon as you remember.
You should not take a double dose to make up for a forgotten dose.
If you are considering stopping treatment before the scheduled end date, you should always consult your doctor.
If you have any further doubts about using this medicine, you should consult your doctor or pharmacist.
Like all medicines, Naltex can cause side effects, although not everybody gets them.
Naltex may affect liver function. Your doctor may perform a blood test before starting treatment and during treatment to monitor liver function.
If you experience any of the following symptoms, you should stoptaking Naltex and immediately consultyour doctor:
You should immediately consult your doctor if you experience any of the following symptoms:
If you experience any side effects, including any possible side effects not listed in this leaflet, you should tell your doctor or pharmacist. Side effects can be reported directly to the Department of Monitoring of Adverse Reactions to Medicinal Products, Office for Registration of Medicinal Products, Medical Devices and Biocidal Products, Al. Jerozolimskie 181C, 02-222 Warsaw, tel.: +48 22 49 21 301, fax: +48 22 49 21 309, website: https://smz.ezdrowie.gov.pl.
By reporting side effects, you can help provide more information on the safety of this medicine.
The medicine should be stored out of sight and reach of children.
Do not use this medicine after the expiry date stated on the packaging. The expiry date refers to the last day of the month.
There are no special precautions for storage.
Medicines should not be disposed of via wastewater or household waste. You should ask your pharmacist how to dispose of medicines that are no longer needed. This will help protect the environment.
Naltex tablets are yellow, oval, biconvex and coated, with a dividing line on one side and no marking on the other.
The tablet can be divided into two equal doses.
Naltex tablets are packaged in PVC/PE/Aclar-Aluminium blisters, containing 14, 28 and 56 coated tablets, in a cardboard box.
For more detailed information, you should contact the marketing authorization holder or parallel importer.
Accord Healthcare S.L.U.
World Trade Center
Moll de Barcelona, s/n
Edifici Est 6ª planta
08039 Barcelona
Spain
Accord Healthcare Polska Sp. z o.o.
ul. Lutomierska 50
95-200 Pabianice
Poland
Accord Healthcare B.V.
Winthontlaan 200
3526 KV Utrecht
Netherlands
InPharm Sp. z o.o.
ul. Strumykowa 28/11
03-138 Warsaw
InPharm Sp. z o.o. Services sp. k.
ul. Chełmżyńska 249
04-458 Warsaw
Marketing authorization number in Portugal, the country of export:5328919
Country Name | Medicine Name |
Austria | Naltrexone Accord 50 mg Filmtabletten |
Belgium | Naltrexone Accord 50 mg comprimes pellicules/ filmomhulde tabletten/ Filmtabletten |
Bulgaria | Naltrexone Акорд 50 мг филмирани таблетки |
Cyprus | Naltrexone Accord 50 mg Film-coated Tablets |
Denmark | Naltrexone Accord 50 mg filmovertrukne tabletter |
Estonia | Naltrexone Accord 50 mg õhukese polümeerikattega tabletid |
Finland | Naltrexone Accord 50 mg kalvopäällysteinen tabletti/ filmdragerade tabletter |
Spain | Tranalex 50 mg comprimidos recubiertos con pelicula EFG |
Netherlands | Naltrexonhydrochloride Accord 50 mg filmomhulde tabletten |
Ireland | Naltrexone Hydrochloride 50 mg Film-coated Tablets |
Lithuania | Naltrexone Accord 50 mg plėvele dengtos tabletės |
Latvia | Naltrexone Accord 50 mg apvalkotās tabletes |
Malta | Naltrexone Hydrochloride 50 mg Film-coated Tablets |
Germany | Naltrexonhydrochlorid Accord 50 mg Filmtabletten |
Norway | Naltrexone Accord 50 mg Filmdrasjert tablett |
Poland | Naltex, 50 mg, tabletki powlekane |
Portugal | Naltrexona Accord 50 mg comprimidos revestidos por película |
Sweden | Naltrexone Accord 50 mg filmdragerad tablet |
United Kingdom (Northern Ireland) | Naltrexone Hydrochloride 50 mg Film-coated Tablets |
Italy | Naltrexone Accord Healthcare 50 mg compresse rivestite con film |
[Information about the trademark]
Need help understanding this medicine or your symptoms? Online doctors can answer your questions and offer guidance.